K252a induces cell cycle arrest and apoptosis by inhibiting Cdc2 and Cdc25c

Cancer Investigation

Volumn 17, Issue 6, 1999, Pages 391-395

  Chin, Lawrence S ^a,b   Murray, Susan F ^a   Doherty, Patrick F ^a   Singh, Satyendra K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Department of Neurosurgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAZOLE DERIVATIVE; CYCLIN DEPENDENT KINASE; K 252A; PLATELET DERIVED GROWTH FACTOR; PROTEIN P21; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE PHASE; DRUG MECHANISM; ENZYME INHIBITION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0032775345     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909021430     Document Type: Article

References (25)

1. Salcman M: Epidemiology and factors affecting survival. In: Malignant Cerebral Glioma, edited by MLJ Apuzzo, Park Ridge, IL, American Association of Neurological Surgeons, 1990, p. 95.
2. Koizumi S, Contreras ML, Matsuda Y, et al: K252a: a specific inhibitor of the action of nerve growth factor on PC12 cells. J Neurosci 8:715-721, 1988.
3. Kwon TK, Buchholz MA, Chrest FJ, et al: Staurosporine-induced G1 arrest is associated with the induction and accumulation of cyclin-dependent linase inhibitors. Cell Growth Diff 7:1305-1313, 1996.
4. Hall LL, Th'ng J, Guo XW, et al: A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation. Cancer Res 56:3551-3559, 1996.
5. Gadbois DM, Hamaguchi JR, Swank RA, et al: Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases. Biochem Biophys Res Commun 184:80-85, 1992.
6. Tam SW, Schlegel R: Staurosporine overrides checkpoints for mitotic onset in BHK cells. Cell Growth Diff 3:811-817, 1992.
7. Chin LS, Murray SF, Zitnay KM, et al: K252a inhibits glioma proliferation by blocking PDGF signal transduction. Clin Cancer Res 3:771-776, 1997.
8. Usui T, Yoshida M, Abe K, et al: Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K252a. J Cell Biol 115:1275-1282, 1991.
9. Atherton-Fessler S, Hannig G, Piwnica-Worms H: Reversible tyrosine phosphorylation and cell cycle control. Semin Cell Biol 4: 433-442, 1993.
10. 2+-dependent protein kinase. Biochem Biophys Res Commun 135:397-402, 1986.
11. Baltuch G, Couldwell WT, Villemure JG, et al: Protein kinase C inhibitors suppress cell growth in established and low passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 33:495-501, 1993.
12. Lewin B: Driving the cell cycle: M phase kinase, its partners, and substrates. Cell 61:743-752, 1990.
13. D'Urso G, Marraccino RL, Marshak DR, et al: Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase. Science 250:786-791, 1990.
14. Nakayama T, Hashimoto Y, Kaneko Y, et al: K252a: a new blocker of the cell-cycle at G1 phase in a human hepatoma cell line. Experientia 49:876-880, 1993.
15. Nakayama T, Hashimoto Y, Kaneko Y, et al: K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells. Biochem Biophys Res Commun 224:180-183, 1996.
16. Couldwell WT, Hinton DR, He S, et al: Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 345:43-46, 1994.
17. Shi L, Nishioka WK, Th'ng J, et al: Premature p34cdc2 activation required for apoptosis. Science 263:1143-1145, 1994.
18. Yao S-L, McKenna KA, Sharkis SJ, et al: Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1b-converting enzyme-related proteases. Cancer Res 56:4551-4555, 1996.
19. Eastman A: Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2:275-280, 1990.
20. Ucker DS: Death by suicide: one way to go in mammalian cellular development. New Biol 3:103-109, 1997.
21. Heald R, McLoughlin M, McKeon F: Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 74:463-474, 1993.
22. Qin X-Q, Livingston D, Kaelin WG, et al: Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91:10918-10922, 1994.
23. Shan B, Lee W-H: Deregulated expression of E2F1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14:8166-8172, 1994.
24. Wu X, Levine AL: p53 and E2F1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91:3602-3606, 1994.
25. Norbury C, MacFarlane M, Fearnhead H, et al: CDC2 activation is not required for thymocyte apoptosis. Biochem Biophys Res Commun 202:1400-1406, 1994.